Form 4: Director Louis Sterling III Executes RSU Vesting

Amarin Corporation director Louis Sterling III acquired 838 American Depositary Shares via RSU vesting, with 403 shares withheld for tax obligations.

Summary

• Director Louis Sterling III acquired 838 American Depositary Shares (ADS) on April 18, 2026, through the vesting of Restricted Stock Units (RSUs).
• The company withheld 403 shares to satisfy tax liabilities associated with the vesting event, priced at $14.98 per share.
• Following these transactions, the director holds a total of 4,049 American Depositary Shares.
• The transaction reflects the vesting of an award granted on April 18, 2024, which vests in three equal annual installments.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a routine administrative transaction related to pre-existing compensation agreements rather than a change in strategic direction or market sentiment.

Positives

• Director maintains a significant equity stake of 4,049 shares in the company.
• The transaction was a routine vesting event rather than a discretionary market sale.

Negatives

• The company withheld 403 shares to cover tax liabilities, reducing the net shares added to the director's holdings.

Risks

• The company is subject to volatility in the value of American Depositary Shares.
• Future vesting and tax withholding events may continue to impact the director's net share ownership.

Future Outlook

The remaining portion of the RSU grant is scheduled to vest on April 18, 2027, subject to the director's continued service.

Management Comments

• The filing notes that the tax withholding was incident to the vesting of a security issued in accordance with Rule 16b-3 and not a market sale.

Industry Context

StockSavvy.ai notes that routine RSU vesting for directors is standard corporate governance practice in the pharmaceutical sector, intended to align long-term interests between management and shareholders.

Comparison to Industry Standards

• The use of RSU vesting schedules is consistent with standard executive compensation practices among mid-cap biotechnology firms.
• Tax withholding at vesting is a standard administrative procedure for equity-based compensation.

Corporate Governance

Stakeholder Impact

• Minimal impact on shareholders as the transaction is a standard equity compensation settlement.

Next Steps

• Final vesting of the remaining RSU installment scheduled for April 18, 2027.

Key Dates

Keywords

Amarin, AMRN, Insider Trading, Form 4, Equity Compensation, Director Ownership